Marker counter-selection via CRISPR/Cas9 co-targeting for efficient generation of genome edited avian cell lines and germ cells

被引:2
|
作者
Challagulla, Arjun [1 ]
Shi, Shunning [1 ]
Nair, Kiran [1 ]
O'Neil, Terri E. [1 ]
Morris, Kirsten R. [1 ]
Wise, Terry G. [1 ]
Cahill, David M. [2 ]
Tizard, Mark L. [1 ]
Doran, Timothy J. [1 ]
Jenkins, Kristie A. [1 ]
机构
[1] CSIRO Hlth & Biosecur, Australian Ctr Dis Preparedness, Geelong, Vic, Australia
[2] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic, Australia
关键词
CRISPR; Cas9; co-targeting; chicken; primordial germ cells; SURROGATE REPORTER; ENRICHMENT; MUTATIONS;
D O I
10.1080/10495398.2021.1885428
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Efficient isolation of genetically modified cells that are phenotypically indistinguishable from the unmodified cells remains a major technical barrier for the broader utilization of CRISPR/Cas9. Here, we report a novel enrichment approach to select the genome engineered cells by co-targeting a genomically integrated GFP gene along with the endogenous gene of interest (GOI). Using this co-targeting approach, multiple genomic loci were successfully targeted in chicken (DF1) and quail (CEC-32) fibroblast cell lines by transient transfection of Cas9 and guide RNAs (gRNAs). Clonal isolation of co-targeted DF1 cells showed 75% of cell clones had deletion of GFP and biallelic deletion of the GOI. To assess the utility of this approach to generate genome modified animals, we tested it on chicken primordial germ cells (PGCs) expressing GFP by co-targeting with gRNAs against GFP and endogenous ovomucoid (OVM) gene. PGCs enriched for loss of GFP and confirmed for OVM deletion, derived by co-targeting, were injected into Hamburger and Hamilton stage 14-15 chicken embryos, and their ability to migrate to the genital ridge was confirmed. This simple, efficient enrichment approach could easily be applied to the creation of knock-out or edited cell lines or animals.
引用
收藏
页码:1235 / 1245
页数:11
相关论文
共 24 条
  • [21] Toward Genosafe Endonuclease-Boosted Gene Targeting Using Breakthrough CRISPR/Cas9 for Next Generation Stem Cell Gene Therapy Culminating in Efficient Ex Vivo/In Vivo Gene Repair/Genomic Editing
    Bertolotti, Roger
    MOLECULAR THERAPY, 2015, 23 : S139 - S139
  • [22] Generation of TRIM28 Knockout K562 Cells by CRISPR/Cas9 Genome Editing and Characterization of TRIM28-Regulated Gene Expression in Cell Proliferation and Hemoglobin Beta Subunits
    Chang, Yao-Jen
    Kang, Zhifu
    Bei, Jiayuan
    Chou, Shu-Jen
    Lu, Mei-Yeh Jade
    Su, Yu-Lun
    Lin, Sheng-Wei
    Wang, Hsin-Hui
    Lin, Steven
    Chang, Ching-Jin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
  • [23] Generation of iTAF1-36-H8.1 and iTAF1-36-H8.2 Human-Induced Pluripotent Stem Cell Lines with HAR Deletion in the CNTN6 Gene by CRISPR/Cas9 Genome-Editing Technology
    Chvileva, A. S.
    Yunusova, A. M.
    Pristyazhnyuk, I. E.
    Smirnov, A. V.
    Ryzhkova, A. S.
    Belokopytova, P. S.
    Shnaider, T. A.
    RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY, 2024, 55 (05) : 296 - 306
  • [24] Generation of three CRISPR/Cas9 edited human induced pluripotent stem cell lines (DHMi005-A-5, DHMi005-A-6 and DHMi005-A-7) carrying a Holt-Oram Syndrome patient-specific TBX5 mutation with known cardiac phenotype and a FLAG-tag after exon 9 of the TBX5 gene
    Lahm, H.
    Stieglbauer, S.
    Neb, I.
    Doppler, S.
    Schneider, S.
    Dzilic, E.
    Lange, R.
    Krane, M.
    Dressen, M.
    STEM CELL RESEARCH, 2023, 69